Cargando…
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC
Autores principales: | Wall, Emma C, Wu, Mary, Harvey, Ruth, Kelly, Gavin, Warchal, Scott, Sawyer, Chelsea, Daniels, Rodney, Adams, Lorin, Hobson, Philip, Hatipoglu, Emine, Ngai, Yenting, Hussain, Saira, Ambrose, Karen, Hindmarsh, Steve, Beale, Rupert, Riddell, Andrew, Gamblin, Steve, Howell, Michael, Kassiotis, George, Libri, Vincenzo, Williams, Bryan, Swanton, Charles, Gandhi, Sonia, Bauer, David LV |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238446/ https://www.ncbi.nlm.nih.gov/pubmed/34197809 http://dx.doi.org/10.1016/S0140-6736(21)01462-8 |
Ejemplares similares
-
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
por: Wall, Emma C, et al.
Publicado: (2021) -
Three-dose vaccination elicits neutralising antibodies against omicron
por: Wu, Mary, et al.
Publicado: (2022) -
Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection
por: Carr, Edward J, et al.
Publicado: (2023) -
AZD-1222: Guillain-Barre syndrome
Publicado: (2021) -
AZD-1222: Rhabdomyolysis: case report
Publicado: (2022)